Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CIRCCa - A Randomized Double Blind Phase II Trial of Carboplatin-Paclitaxel Plus Cediranib Versus Carboplatin-Paclitaxel Plus Placebo in Metastatic/Recurrent Cervical Cancer

NCT01229930 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.

NCT NCT01229930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01229930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CIRCCa - A Randomized Double Blind Phase II Trial of Carboplatin-Paclitaxel Plus Cediranib Versus Carboplatin-Paclitaxel Plus Placebo in Metastatic/Recurrent Cervical Cancer
Lead sponsor
University of Glasgow
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2012
Enrollment
130 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer